Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial-Reference-Cited by-同舟云学术

Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial

Published:2019-04 Issue:4 Volume:70 Page:684-691
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Park Joong-Won^ORCID,Kim Yoon Jun,Kim Do Young,Bae Si-Hyun,Paik Seung Woon,Lee Youn-Jae,Kim Hwi Young,Lee Han Chu,Han Sang Young,Cheong Jae Youn,Kwon Oh Sang,Yeon Jong Eun,Kim Bo Hyun,Hwang Jaeseok

Funder

National Cancer Center, Korea

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015;Global Burden of Disease Liver Cancer C;JAMA Oncol,2017

2. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study;Park;Liver Int,2015

3. Epidemiology of liver cancer in South Korea;Kim;Clin Mol Hepatol,2018

4. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?;Liver Research;2024-09

2. Phase I–IV Drug Trials on Hepatocellular Carcinoma in Asian Populations: A Systematic Review of Ten Years of Studies;International Journal of Molecular Sciences;2024-08-27

3. Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment;Journal of the Formosan Medical Association;2024-07

4. Lenvatinib in combination with transarterial chemoembolization vs. sorafenib in combination with transarterial chemoembolization for unresectable hepatocellular carcinoma: A network meta‑analysis;Oncology Letters;2024-06-03

5. Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus;JAMA Surgery;2024-06-01